Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy

Intern Med. 2023 Sep 15;62(18):2747-2751. doi: 10.2169/internalmedicine.1275-22. Epub 2023 Feb 8.

Abstract

A 69-year-old man with a history of anti-synthetase antibody-positive polymyositis and interstitial lung disease (ILD) stable for more than 20 years suddenly developed pulmonary artery hypertension (PAH) with a mean PA pressure of 46 mmHg. At this stage, ILD was mild, but it became acutely exacerbated later, and high-dose corticosteroid and intravenous cyclophosphamide ameliorated both PAH and ILD. The tricuspid regurgitation pressure gradient decreased from 80 to 49 mmHg and ILD recovered almost completely. During a systemic examination, bone metastatic cancer of unknown origin was found. We herein report the relationship between anti-synthetase syndrome (ASS) and PAH as well as ASS and malignancy.

Keywords: anti-synthetase syndrome; interstitial lung disease; malignancy; polymyositis; pulmonary arterial hypertension.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Lung Diseases, Interstitial* / complications
  • Lung Diseases, Interstitial* / drug therapy
  • Male
  • Neoplasms*
  • Polymyositis*
  • Pulmonary Arterial Hypertension*
  • Retrospective Studies